- About Us
- Plastic Surgery
- Weight Loss
- Aesthetics Center
- Areas Served
- Contact Us
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood glucose (sugar). GLP-1 in higher amounts also interacts with the parts of the brain that reduce appetite and signal a feeling of fullness.
Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist. Tirzepatide is a single molecule that activates the body’s receptors for GIP and GLP-1, which are natural incretin hormones. Both GIP and GLP-1 receptors are found in areas of the human brain important for appetite regulation. Tirzepatide has been shown to decrease food intake and modulate fat utilization.
BPC 157 is a pentadecapeptide, a chain of 15 amino acids derived from human gastric juice. It is a very stable peptide that interacts with a variety of cellular pathways. BPC 157 can influence processes such as tissue regeneration, inflammation, and angiogenesis (the formation of new blood vessels). While much of the current research has centered on its ability to aid digestion and help treat irritable bowel syndrome (IBS), growing data shows BPC 157 may also have other therapeutic properties.